These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32214233)

  • 1. Molecular epigenomic subtypes of Barrett neoplasia.
    Meltzer SJ
    Nat Rev Gastroenterol Hepatol; 2020 May; 17(5):261-262. PubMed ID: 32214233
    [No Abstract]   [Full Text] [Related]  

  • 2. Anterior gradient 2 profiling in Barrett columnar epithelia and adenocarcinoma.
    Pizzi M; Fassan M; Realdon S; Balistreri M; Battaglia G; Giacometti C; Zaninotto G; Zagonel V; De Boni M; Rugge M
    Hum Pathol; 2012 Nov; 43(11):1839-44. PubMed ID: 22521076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Kaz AM; Grady WM; Stachler MD; Bass AJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):473-89. PubMed ID: 26021206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the serine/threonine protein kinase Akt during the progression of Barrett neoplasia.
    Sagatys E; Garrett CR; Boulware D; Kelley S; Malafa M; Cheng JQ; Sebti S; Coppola D
    Hum Pathol; 2007 Oct; 38(10):1526-31. PubMed ID: 17640711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of c-myb in reflux esophagitis, Barrett esophagus and esophageal adenocarcinoma].
    Ren CR; Dong L; Guo XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2693-5. PubMed ID: 21177182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
    Chang JT; Katzka DA
    Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett esophagus and adenocarcinoma.
    Chen MY; Frederick MG
    Radiol Clin North Am; 1994 Nov; 32(6):1167-81. PubMed ID: 7972706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma.
    di Martino E; Hardie LJ; Wild CP; Gong YY; Olliver JR; Gough MD; Bird NC
    Genet Med; 2007 Jun; 9(6):341-7. PubMed ID: 17575500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of Barrett esophagus and esophageal adenocarcinoma.
    Singh T; Sanghi V; Thota PN
    Cleve Clin J Med; 2019 Nov; 86(11):724-732. PubMed ID: 31710585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics: DNA Methylation Analysis in Esophageal Adenocarcinoma.
    Islam F; Tang JC; Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():247-256. PubMed ID: 29600375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction.
    Hamilton SR; Smith RR; Cameron JL
    Hum Pathol; 1988 Aug; 19(8):942-8. PubMed ID: 3402983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.
    Yu M; Maden SK; Stachler M; Kaz AM; Ayers J; Guo Y; Carter KT; Willbanks A; Heinzerling TJ; O'Leary RM; Xu X; Bass A; Chandar AK; Chak A; Elliott R; Willis JE; Markowitz SD; Grady WM
    Gut; 2019 Mar; 68(3):389-399. PubMed ID: 29884612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin use and the risk of esophageal cancer in Barrett esophagus.
    Agrawal S; Patel P; Agrawal A; Makhijani N; Markert R; Deidrich W
    South Med J; 2014 Dec; 107(12):774-9. PubMed ID: 25502158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
    Shaheen N; Ransohoff DF
    JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction.
    Eng C; Spechler SJ; Ruben R; Li FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):397-9. PubMed ID: 8348064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the Detection of Barrett Esophagus.
    Komatsu Y; Newhams KM; Jobe BA
    Thorac Surg Clin; 2018 Nov; 28(4):453-464. PubMed ID: 30268291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the rat be used as a valid model of human esophageal adenocarcinoma?
    Hindmarsh A; Belshaw N; Mehta S; Johnson IT; Rhodes M
    Dis Esophagus; 2012 Feb; 25(2):159-65. PubMed ID: 21819480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.